Cardlytics (CDLX) stock price, revenue, and financials

Cardlytics market cap is $3.2 b, and annual revenue was $210.43 m in FY 2019

$3.2 B

CDLX Mkt cap, 03-Dec-2020

$45.5 M

Cardlytics Revenue Q1, 2020
Cardlytics Gross profit (Q1, 2020)16 M
Cardlytics Gross profit margin (Q1, 2020), %35.1%
Cardlytics Net income (Q1, 2020)-13.5 M
Cardlytics EBIT (Q1, 2020)-11.9 M
Cardlytics Cash, 31-Mar-2020102.2 M
Cardlytics EV3.1 B

Cardlytics Revenue

Cardlytics revenue was $210.43 m in FY, 2019 which is a 39.6% year over year increase from the previous period.

Embed Graph

Cardlytics Revenue Breakdown

Embed Graph

Cardlytics revenue breakdown by business segment: 100.0% from Cardlytics Direct and 0.0% from Other

Cardlytics revenue breakdown by geographic segment: 88.8% from United States and 11.2% from United Kingdom

Cardlytics Income Statement

Annual

USDFY, 2017FY, 2018FY, 2019

Revenue

130.4m150.7m210.4m

Revenue growth, %

16%16%40%

Cost of goods sold

80.3m96.0m131.0m

Gross profit

50.1m54.7m79.5m

Gross profit Margin, %

38%36%38%

Sales and marketing expense

31.9m41.9m43.8m

R&D expense

12.2m16.2m11.7m

General and administrative expense

20.1m34.2m36.7m

Operating expense total

67.2m95.6m96.8m

Depreciation and amortization

3.0m3.3m4.5m

EBIT

(17.1m)(40.9m)(17.3m)

EBIT margin, %

(13%)(27%)(8%)

Interest expense

8.2m3.3m548.0k

Pre tax profit

(19.6m)(53.0m)(17.1m)

Net Income

(19.6m)(53.0m)(17.1m)

EPS

(7.9)(2.8)(0.7)

Cardlytics Balance Sheet

Annual

USDFY, 2017FY, 2018FY, 2019

Cash

21.3m39.6m104.5m

Accounts Receivable

48.3m58.1m81.5m

Current Assets

74.6m4.0m195.7m

PP&E

7.3m10.2m14.3m

Total Assets

100.8m153.8m224.3m

Accounts Payable

1.6m2.1m1.2m

Short-term debt

44.0k21.0k24.0k

Current Liabilities

42.1m51.9m78.4m

Long-term debt

57.0m46.7m13.0k

Non-Current Liabilities

70.9m

Total Debt

57.0m46.7m37.0k

Total Liabilities

101.8m81.0m

Common Stock

7.0k8.0k

Additional Paid-in Capital

58.7m371.5m480.6m

Retained Earnings

(268.4m)(321.5m)(338.6m)

Total Equity

(208.7m)52.0m143.3m

Debt to Equity Ratio

-0.3 x0.9 x0 x

Debt to Assets Ratio

0.6 x0.3 x0 x

Financial Leverage

-0.5 x3 x1.6 x

Cardlytics Cash Flow

Annual

USDFY, 2017FY, 2018FY, 2019

Net Income

(19.6m)(53.0m)(17.1m)

Depreciation and Amortization

3.0m3.3m4.5m

Accounts Receivable

(7.5m)(9.4m)(26.0m)

Accounts Payable

(1.9m)911.0k(601.0k)

Cash From Operating Activities

(2.5m)(19.0m)11.5m

Purchases of PP&E

(1.2m)(5.9m)(8.3m)

Cash From Investing Activities

(1.6m)(7.3m)(11.0m)

Long-term Borrowings

(99.0k)(52.6m)(46.7m)

Cash From Financing Activities

21.8m65.2m44.2m

Net Change in Cash

(1.7m)38.6m44.7m

Interest Paid

873.0k1.3m

Quarterly

Cardlytics Ratios

USDFY, 2017

Revenue/Employee

378.7k

Debt/Equity

-0.3 x

Debt/Assets

0.6 x

Financial Leverage

-0.5 x

Cardlytics Operating Metrics

Cardlytics's Monthly Active Users was reported to be 140.8 m in Q1, 2020.
FY, 2017Feb, 2018Q1, 2018Q2, 2018Q3, 2018FY, 2018Q1, 2019Q2, 2019Q3, 2019FY, 2019Q1, 2020

Monthly Active Users

54.94 m58.68 m58.81 m59.33 m65.01 m108.47 m120.13 m128.32 m122.59 m140.78 m

ARPU

$2.23 $0.55 $0.60 $0.58 $2.30 $0.33 $0.40 $0.44 $1.72 $0.32

Online and In-store Transactions Analyzed

20 b35 b

U.S. Accounts Analyzed

100 m175 m

Patents Issued

3 4 4 4 4 4 4 4 4 4

Patents Pending

10 4 6 5 5 5 5 5 10 10

Clients

2.04 k

Cardlytics Employee Rating

3.4109 votes
Culture & Values
3.6
Work/Life Balance
3.5
Senior Management
2.9
Salary & Benefits
3.3
Career Opportunities
3.1
Source